ScienceGeist

Six researchers offer tips for navigating through and beyond gender barriers.

Nick Fowler and Gerard Meijer on the future of Open Access in Germany. Will the negotiations continue?

Physicist Jana Lasser of PhDnet discusses the group's new report.

An interview with the directors of PsyArxiv, SocArxiv, and Marxiv.

Representative Bill Foster weighs in on the most important science issues facing the country.

The Nobel prize-winning biologist and president of the Royal Society on how Brexit might affect the sciences.

"It's hard to see yourself in a career where you don't see other people who are like you."

Only about 5% of the institutions made explicit mention of open access in their guidelines, and, in several of those few cases, the mention was done to call attention to the potentially problematic nature of these journals.

In an era when untestable ideas such as the multiverse hold sway, Michela Massimi defends science from those who think it hopelessly unmoored from physical reality.

Catherine Winchester was hired to ferret out errors and establish routines that promote rigorous research.

Wellcome Trust's Director of Science Jim Smith addresses how Wellcome should identify the most able and dedicated researchers, and how it should support, and recognise, team science.

The Swiss universities are negotiating with the world’s three largest scientific publishers for fair – in other words affordable – terms of access. Michael Hengartner, president of swissuniversities and UZH, explains the background.

A researcher explains how - and why - he spent a whole summer harvesting information from the platform, which is notoriously hard to mine.

"If you [only] have products created by white guys in their 20s, you’re gonna miss the mark."

On his last day in one of the most powerful research seats in Europe, Robert-Jan Smits talks about his legacy and the future.

Lutz Jäncke and Lawrence Rajendran talk about the crisis in the publication process and new solutions.

An interview presents the perspectives of Jonathan Tennant, an early-career researcher.

Terence Karran is fighting for a European agreement to enshrine researchers’ rights: a ‘Magna Carta’ for science.

Using a database of 750 cases of research fraud from around the world, professors examine fraud as a phenomenon, tracing its history and trajectory and looking at what can be done about it.

Biologists' positive personal experiences with preprints.

Retraction Watch interviews Irene Hames.

We talk to Dr Richard Bowman about designing 3D-printable microscopes.

High-risk, high-reward ideas in areas such as AI, blockchain and synthetic biology are typical contenders for support from the EU’s new Innovation Council.

Carlos Moedas, EU Commissioner for Research, Science and Innovation, has called for political leaders to speak more about science and innovation to connect people with the life-changing research that is funded by their taxes and has the potential to combat urgent global problems.

EMBL-EBI’s open chemistry data services combine curiosity-driven science and pragmatic solution-finding for drug discovery.

Physicist John Holdren was for 8 years Obama’s top aide on science and technology issues.

The next EU research funding programme should be doubled in size to help fix Europe's growth problems, according to former World Trade Organization chief Pascal Lamy.

Crispr inventor Jennifer Doudna talks about discovering the gene-editing tool, the split with her collaborator and the complex ethics of genetic manipulation.